Dr Mark Eccleston-Turner is a Lecturer in Law at Keele University. He holds a Bachelor of Laws from the University of Wales, Aberystwyth, and a Master of Laws with distinction in Medical Law and Ethics from the University of Edinburgh. His doctorate was awarded by the University of Manchester in 2016 for a thesis entitled: “The PIP Framework and Access to Pandemic Influenza Vaccines: Procurement Options for Developing States.” Within this, he focussed on international law, access and benefit regimes, vaccine procurement, and intellectual property rights in the context of access to pandemic influenza vaccines.
His research specialism is in the field of international law and infectious diseases. Within this, his research interests lie in the field of pandemic influenza preparedness and access to vaccines, and the law of international organizations in the context of global health. He has published extensively on access to pandemic vaccine issues, including on issues of vaccine procurement for developing countries, and equitable access models.
Mark has advice and consultancy to the UK Foreign and Commonwealth Office and Department for International Development on matters of international law, and is a member of UK Parliament COVID-19 Outbreak Expert Database. He has appeared as a witness before the Foreign Affairs Select Committee, and provided evidence to the Joint Committee on the National Security. Mark has held visiting positions at the Brocher Foundation, in Geneva, Georgetown University School of Law, and as an Emerging Leader in Biosecurity Fellow at the Johns Hopkins Center for Health Security. Dr Eccleston-Turner has also worked as a Consultant to the World Health Organisation on procurement of pandemic vaccines.
Mark regularly appears in national and international media to discuss internaitonal law and infectious diseases. His interviews have appeared on: Al Jazeera TV, Euronews, BBC News, Sky News, New York Times, Washington Post, South China Morning Post, and The Times.
Mark is an experienced doctoral supervisor, and welcomes PhD proposals in the field of Global Health Law.
Research and scholarship
Mark’s research specialism is in the field of international law and infectious diseases.
His research is primarily focussed on the response to emerging infectious diseases in international law, and the law of international organisations in the context of global health. This is a growing specialism within international law and of increasing importance as the recent Ebola and novel coronavirus outbreaks have demonstrated. Mark has published extensively on both of these topics, and his work has been cited extensively in the literature, and in numerous meetings, reports, and consultations at the international level.
Mark is currently the principal investigator on two projects:
‘Assessing the viability of access and benefit-sharing models of equitable distribution of vaccines in international law’ (£125,000, AHRC)
'Tracking the Transfer of Pandemic Influenza Viruses', (£18,000, Open Philanthropy)
Mark is also a member of the International Law Impact and Infectious Disease (ILIAID) Consortium brings together academics, lawyers, researchers, and policy-makers from diverse backgrounds and disciplines to examine issues relating to governance and the impact of international law on infectious diseases.
Controversies in Intellectual Property Law
Mark teaches across a number of postgraduate, including: Advanced International Law; Health, Justice and Society; Life, Death, and the Human Body, and Dissertation.
Mark leads the Global Health Law module on the International Law Masters programme.
Mark regularly tweets on issues related to international law and infectious diseases at @markRturner
Eccleston-Turner M.R, ‘The U.K’s engagement with international biosecurity’ ‘for the Biosecurity and human health: preparing for emerging infectious diseases and bioweapons Strategy' inquiry by the Joint Committee on the National Security (9th September 2019) at: http://data.parliament.uk/writtenevidence/committeeevidence.svc/evidencedocument/national-security-strategy-committee/biosecurity-and-human-health-preparing-for-emerging-infectious-diseases-and-bioweapons/written/105037.pdf
Invited Presentations and Keynote Addresses
- Eccleston-Turner M.R, ‘The declaration of a Public Health Emergency of International Concern: implications for international law’ Johns Hopkins University Seminar Series (June 2020)
- Eccleston-Turner M.R, ‘Why international law matters for global health security’ Distinguished Visiting Professor inaugural lecture, Georgetown University (June, 2020)
- Eccleston-Turner M.R(co-presenter), ‘Has international law prepared us for the next pandemic? The International Health Regulations on Trial’ Public Lecture University of Sydney (2019)
- Eccleston-Turner M.R, discussant on treaty design at the Expert Workshop on an International Legal Agreement for Managing the Global Antimicrobial Commons, University of Oxford (2019)
- Eccleston-Turner M.R, participant in the inaugural Consensus Conference on Global Health Law, University of Stellenbosch (2019)
- Eccleston-Turner M.R, ‘The universalism of legal subjects, and power in global health’ Plenary address, to the European Society of International Law, University of Manchester (2018)
- Eccleston-Turner, “The regulation of non-state actors in global health security” Wellcome Trust Workshop on Global Health Security and Universal Health Coverage, University of Edinburgh (2018)
Select Conference Presentations
- Eccleston-Turner, M.R, ’Is global health law driven by process out outcome? SLSA, University of Portsmouth (2020)
- Eccleston-Turner, M.R & Phelan A, ‘Legal barriers to the sharing of influenza vaccines with GISRS: implications for global health security’ Global Health Security, Sydney (2019)
- Eccleston-Turner, M.R ‘Influenza vaccine security and supply during a pandemic: compulsory requisition and Force Majeure’ Global Health Security, Sydney (2019)
- Eccleston-Turner M.R, ‘Securitising climate change’: lessons from the global health security agenda’ Max Planck Institute for International Law Workshop on Global Health and Environmental Law, Heidelberg (2018)
- Eccleston-Turner M.R, ‘Establishing pandemic influenza vaccine manufacturing capacity in developing states: is a knowledge clearing house required?’ World Congress of the International Academy of Medical Ethics and Public Health, Prague (2017)
- Eccleston-Turner M.R, ‘The economic theory of patent protection and pandemic influenza vaccines: do patents really incentivise innovation?’ American Journal of law & Medicine Symposium, Boston (2016)
Full Publications Listshow
Eccleston-Turner M and Brassington I (Eds.). Infectious Diseases in the New Millennium: Legal and Ethical Challenges. Springer. link>
Inter-Institutional Relationships in Global Health: Regulating Coordination and Ensuring Accountability. Global Health Governance. full text>2018.
Operationalizing the Right to Health through the Pandemic Influenza Preparedness Framework. Global Health Governance, 22-34, vol. XII(1). full text>2018.
Accountability, international law, and the World Health Organization: A need for reform?. Global Health Governance, 27-40, vol. XI(1).2017.
The Economic Theory of Patent Protection and Pandemic Influenza Vaccines Do Patents Really Incentivize Innovation in the Field?. American Journal of Law and Medicine -Boston-, 572-597, vol. 42(2). doi>2016.
The global governance of HIV/AIDS: Intellectual property and access to essential medicines. Global Public Health, 1117-1118, vol. 9(9). doi>2015.